Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus

Rheumatology

Volumn 51, Issue 3, 2012, Pages 468-475

  Mok, Chi Chiu ^a   Wong, Sik Nin ^a   Ma, Kwok Man ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Complication; Fracture; Lupus; Morbidity; Osteoporosis

Indexed keywords

AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; VITAMIN D;

ARTICLE; BODY MASS; BONE DENSITY; DISEASE DURATION; DRUG MEGADOSE; FEMALE; FEMUR NECK; GENDER; HIP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; AGE OF ONSET; BODY MASS INDEX; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOCORTICOIDS; HIP; HUMANS; INCIDENCE; LINEAR MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPINE; YOUNG ADULT;

EID: 84857588448     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker306     Document Type: Article

References (31)

1. Lee C, Ramsey-Goldman R. Osteoporosis in systemic lupus erythematosus mechanisms. Rheum Dis Clin North Am 2005;31:363-85, viii.
2. Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol 2010;6:538-46.
3. McLean RR. Proinflammatory cytokines and osteoporosis. Curr Osteoporos Rep 2009;7:134-9.
4. Li EK, Tam LS, Young RP, Ko GT, Li M, Lau EM. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol 1998;37:405-10.
5. Pons F, Peris P, Guanabens N et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995;34:742-6.
6. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
7. Ramsey-Goldman R, Dunn JE et al. Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data. Arthritis Rheum 1999; 42:882-90.
8. Yee CS, Crabtree N, Skan J et al. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 2005;64:111-3.
9. Lilleby V, Lien G, Frey Frøslie K, Haugen M, Flatø B, Førre.Ø. Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum 2005;52:2051-9.
10. Compeyrot-Lacassagne S, Tyrrell PN et al. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum 2007;56: 1966-73.
11. Trapani S, Civinini R, Ermini M, Paci E, Falcini F. Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int 1998;18:45-9.
12. Huber AM, Gaboury I, Cabral DA et al. Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res 2010;62:516-26.
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40: 1725.
14. Looker AC, Wahner HW, Dunn WL et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998;8:468-89.
15. Buyon JP, Petri MA, Kim MY et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005;142:953-62.
16. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
17. Tabensky A, Duan Y, Edmonds J, Seeman E. The contribution of reduced peak accrual of bone and age-related bone loss to osteoporosis at the spine and hip: insights from the daughters of women with vertebral or hip fractures. J Bone Miner Res 2001;16:1101-7.
18. Berger C, Goltzman D, Langsetmo L et al. The CaMos Research Group. Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res 2010;25: 1948-57.
19. Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB. Bone gain in young adult women. JAMA 1992;268:2403-8.
20. Matkovic V, Jelic T, Wardlaw GM et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest 1994;93:799-808.
21. Lu PW, Briody JN, Ogle GD et al. Bone mineral density of total body, spine, and femoral neck in children and young adults: a cross-sectional and longitudinal study. J Bone Miner Res 1994;9:1451-8.
22. Bailey DA, Martin AD, McKay HA, Whiting S, Mirwald R. Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res 2000;15:2245-50.
23. Bonjour JP, Theintz G, Buchs B, Slosman D, Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991;73:555-63.
24. Loud KJ, Gordon CM. Adolescent bone health. Arch Pediatr Adolesc Med 2006;160:1026-32.
25. Compston J. Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol 2010;6:82-8.
26. Simon D. Management of growth retardation in juvenile idiopathic arthritis. Horm Res 2007;68(Suppl 5): 122-5.
27. Mehls O, Tönshoff B, Kovàcs G, Mayer C, Schurek J, Oh J. Interaction between glucocorticoids and growth hormone. Acta Paediatr Suppl 1993;388: 77-82.
28. Schett G, Saag KG, Bijlsma JW. From bone biology to clinical outcome: state of the art and future perspectives. Ann Rheum Dis 2010;69:1415-9.
29. Diarra D, Stolina M, Polzer K et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007;13:156-63.
30. Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporosis Int 2009;20:427-33.
31. Sabry A, Sheashaa H, El-Husseini A et al. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine 2006; 35:148-53.